TY - JOUR
T1 - Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children
AU - Chiba, Naoko
AU - Kobayashi, Reiko
AU - Hasegawa, Keiko
AU - Morozumi, Miyuki
AU - Nakayama, Eiichi
AU - Tajima, Takeshi
AU - Iwata, Satoshi
AU - Ubukata, Kimiko
AU - Endo, Hiroko
AU - Takayanagi, Reiko
AU - Numata, Mika
AU - Ishizawa, Shinobu
AU - Sunakawa, Keisuke
AU - Oishi, Tomohiro
AU - Ohnari, Shigeru
AU - Kawamura, Naohisa
AU - Kuroki, Haruo
AU - Sakai, Ritsuko
AU - Nitta, Masahiko
AU - Morinobu, Takao
AU - Shimizu, Koichi
N1 - Funding Information:
We are sincerely grateful to the physicians in the ARD study group, which was organized for this study. This work was partially supported by two grants, one from the Ministry of Health, Labour, and Welfare of Japan (The Research Project for Emerging and Re-emerging Infectious Diseases, April 2003 to March 2005) and the other from the Japanese Ministry of Education, Culture, Sports, Science and Technology (the 21st Century COE program).
PY - 2005/10
Y1 - 2005/10
N2 - Objectives: Antibiotic susceptibilities, genes mediating β-lactam and macrolide resistance, and serotypes were analysed for strains of Streptococcus pneumoniae. Methods: A total of 392 strains of S. pneumoniae were isolated from paediatric patients with community-acquired pneumonia between May 2002 and 2004. All strains were classified into six genotype patterns according to the mutations found in the pbp1a, pbp2x and pbp2b genes identified by PCR. These results are represented by adding 'g', indicating genotypic identification. Results: Thirty-nine percent of the isolates showed mutations in either one or two PBP genes (gPISP, where PISP stands for penicillin-intermediate resistant S. pneumoniae) and 52.3% had mutations in three genes (gPRSP, where PRSP stands for penicillin-resistant S. pneumoniae). The majority of the strains had a macrolide resistance gene: mef(A), (30.6%); erm(B), (48.5%); or both mef(A) and erm(B), (7.7%). The most frequent serotypes of these strains were: 6B (23.2%), 23F (17.6%), 19F (17.3%), 14 (10.5%) and 6A (8.2%). Serotypes of the seven-valent conjugate vaccine covered 70.9% of all isolates, and 89.8% of gPRSP. Serotypes of the strains with cefotaxime MICs of ≥2 mg/L were almost all of a vaccine type. Conclusions: The results suggest that introduction of conjugate vaccines into infants and children is necessary for the prevention of pneumococcal infections in Japan.
AB - Objectives: Antibiotic susceptibilities, genes mediating β-lactam and macrolide resistance, and serotypes were analysed for strains of Streptococcus pneumoniae. Methods: A total of 392 strains of S. pneumoniae were isolated from paediatric patients with community-acquired pneumonia between May 2002 and 2004. All strains were classified into six genotype patterns according to the mutations found in the pbp1a, pbp2x and pbp2b genes identified by PCR. These results are represented by adding 'g', indicating genotypic identification. Results: Thirty-nine percent of the isolates showed mutations in either one or two PBP genes (gPISP, where PISP stands for penicillin-intermediate resistant S. pneumoniae) and 52.3% had mutations in three genes (gPRSP, where PRSP stands for penicillin-resistant S. pneumoniae). The majority of the strains had a macrolide resistance gene: mef(A), (30.6%); erm(B), (48.5%); or both mef(A) and erm(B), (7.7%). The most frequent serotypes of these strains were: 6B (23.2%), 23F (17.6%), 19F (17.3%), 14 (10.5%) and 6A (8.2%). Serotypes of the seven-valent conjugate vaccine covered 70.9% of all isolates, and 89.8% of gPRSP. Serotypes of the strains with cefotaxime MICs of ≥2 mg/L were almost all of a vaccine type. Conclusions: The results suggest that introduction of conjugate vaccines into infants and children is necessary for the prevention of pneumococcal infections in Japan.
KW - Antibiotic resistance genes
KW - PBPs
KW - Respiratory tract infections
KW - S. pneumoniae
UR - http://www.scopus.com/inward/record.url?scp=27144559589&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27144559589&partnerID=8YFLogxK
U2 - 10.1093/jac/dki302
DO - 10.1093/jac/dki302
M3 - Article
C2 - 16131518
AN - SCOPUS:27144559589
SN - 0305-7453
VL - 56
SP - 756
EP - 760
JO - Journal of Antimicrobial Chemotherapy
JF - Journal of Antimicrobial Chemotherapy
IS - 4
ER -